M, N., H, S., M, S., M, M., K, T., T, F., . . . T, H. (2025). First-line biologics as a treatment for ulcerative colitis: A multicenter randomized control study. Journal of gastroenterology, 60(4), 430. https://doi.org/10.1007/s00535-025-02216-0
Chicago Style (17th ed.) CitationM, Naganuma, et al. "First-line Biologics as a Treatment for Ulcerative Colitis: A Multicenter Randomized Control Study." Journal of Gastroenterology 60, no. 4 (2025): 430. https://doi.org/10.1007/s00535-025-02216-0.
MLA (9th ed.) CitationM, Naganuma, et al. "First-line Biologics as a Treatment for Ulcerative Colitis: A Multicenter Randomized Control Study." Journal of Gastroenterology, vol. 60, no. 4, 2025, p. 430, https://doi.org/10.1007/s00535-025-02216-0.
Warning: These citations may not always be 100% accurate.